Treatment Interventions for the Management of Intestinal Permeability: A Cross-Sectional Survey of Complementary and Integrative Medicine Practitioners

被引:6
作者
Leech, Bradley [1 ,2 ]
Schloss, Janet [1 ]
Steel, Amie [1 ,2 ]
机构
[1] Endeavour Coll Nat Hlth, Off Res, Fortitude Valley, Qld, Australia
[2] Univ Technol Sydney, Fac Hlth, Australian Res Ctr Complementary & Integrat Med, 15 Broadway, Ultimo, NSW 2007, Australia
关键词
naturopathy; intestinal barrier dysfunction; therapeutics; whole system research; exercise; integrative medicine; SACCHAROMYCES-BOULARDII; EPITHELIAL BARRIER; ALTERNATIVE MEDICINE; GUT PERMEABILITY; CROHNS-DISEASE; NITRIC-OXIDE; GASTROINTESTINAL PERMEABILITY; GLUTAMINE SUPPLEMENTATION; MULTIPLE-SCLEROSIS; INDUCED INCREASE;
D O I
10.1089/acm.2018.0374
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objectives: This study aims to explore the treatment interventions complementary and integrative medicine (CIM) practitioners use in the management of an emerging health condition, increased intestinal permeability (IP), and the association these methods have on the observed time to resolve this condition. Design and setting: A cross-sectional survey of Australian naturopaths, nutritionists, and Western herbal medicine practitioners was undertaken (n = 227) through the Practitioner Research and Collaboration Initiative (PRACI) network. Outcome measures: Frequencies and percentages of the treatment methods, including chi-square analysis to examine the associations between treatment methods and observed time to resolve IP. Results: Thirty-six CIM practitioners responded to the survey (response rate 15.9%). CIM practitioners were found to use a multimodal approach in the management of IP with 92.6% of respondents using three or more categories of treatment interventions (nutritional, herbal, dietary, and lifestyle) with a mean total of 43.0 +/- 24.89 single treatment interventions frequently prescribed. The main treatments prescribed in the management of IP were zinc (85.2%), probiotics: multistrain (77.8%), vitamin D (75.0%), glutamine (73.1%), Curcuma longa (73.1%), and Saccharomyces boulardii (70.4%). CIM practitioners also advocate patients with IP to reduce alcohol (96.3%), gluten (85.2%), and dairy (75.0%) consumption. Evaluation of antibiotics (75.0%) and nonsteroidal anti-inflammatory drugs (73.1%) prescriptions were frequently advised by CIM practitioners. A longer observed time to resolve IP was seen in CIM practitioners who did not reduce intense exercise in the management of IP (p = 0.02). Conclusions: This study represents the first survey of the treatments prescribed by CIM practitioners for IP and suggests that CIM practitioners use numerous integrative treatment methods for the management of IP. The treatment interventions frequently prescribed by CIM practitioners align with preclinical research, suggesting that CIM practitioners prescribe in accordance with the published literature. The findings of this study contribute to the implementation of clinical research in the management of IP, which considers multiple concurrent treatments.
引用
收藏
页码:623 / 636
页数:14
相关论文
共 89 条
[1]   Disease Prevention and Health Promotion How Integrative Medicine Fits [J].
Ali, Ather ;
Katz, David L. .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2015, 49 (05) :S230-S240
[2]   Effect of polyunsaturated fatty acids on tight junctions in a model of the human intestinal epithelium under normal and inflammatory conditions [J].
Beguin, Pauline ;
Errachid, Abdelmounaim ;
Larondelle, Yvan ;
Schneider, Yves-Jacques .
FOOD & FUNCTION, 2013, 4 (06) :923-931
[3]   Glutamine and Whey Protein Improve Intestinal Permeability and Morphology in Patients with Crohn's Disease: A Randomized Controlled Trial [J].
Benjamin, Jaya ;
Makharia, Govind ;
Ahuja, Vineet ;
Rajan, K. D. Anand ;
Kalaivani, Mani ;
Gupta, Siddhartha Datta ;
Joshi, Yogendra Kumar .
DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (04) :1000-1012
[4]   Glutamine Restores Tight Junction Protein Claudin-1 Expression in Colonic Mucosa of Patients With Diarrhea-Predominant Irritable Bowel Syndrome [J].
Bertrand, Julien ;
Ghouzali, Ibtissem ;
Guerin, Charlene ;
Bole-Feysot, Christine ;
Gouteux, Melodie ;
Dechelotte, Pierre ;
Ducrotte, Philippe ;
Coeffier, Moise .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2016, 40 (08) :1170-1176
[5]   Intestinal permeability - a new target for disease prevention and therapy [J].
Bischoff, Stephan C. ;
Barbara, Giovanni ;
Buurman, Wim ;
Ockhuizen, Theo ;
Schulzke, Joerg-Dieter ;
Serino, Matteo ;
Tilg, Herbert ;
Watson, Alastair ;
Wells, Jerry M. .
BMC GASTROENTEROLOGY, 2014, 14
[6]  
BJARNASON I, 1984, LANCET, V1, P179
[7]   Mobilising knowledge between practitioners and researchers to iteratively refine a complex intervention (DAFNEplus) pre-trial: Protocol for a structured, collaborative working group process [J].
Breckenridge J.P. ;
Gianfrancesco C. ;
De Zoysa N. ;
Lawton J. ;
Rankin D. ;
Coates E. .
Pilot and Feasibility Studies, 4 (1)
[8]   Genetic basis for increased intestinal permeability in families with Crohn's disease:: role of CARD15 3020insC mutation? [J].
Buhner, S ;
Buning, C ;
Genschel, J ;
Kling, K ;
Herrmann, D ;
Dignass, A ;
Kuechler, I ;
Krueger, S ;
Schmidt, HHJ ;
Lochs, H .
GUT, 2006, 55 (03) :342-347
[9]  
Collins FL, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13263
[10]   A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity [J].
Conaghan, Philip G. .
RHEUMATOLOGY INTERNATIONAL, 2012, 32 (06) :1491-1502